Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders in Children and Adolescents: A Placebo-Controlled, Randomized, Double-Blind Clinical Trial

Thursday, October 20, 2011

Christian Fleischhaker, M.D., Department for Child and Adolescent Psychiatry and Psychotherapy, University Clinic Freiburg, Freiburg, Germany

Klaus Hennighausen, M.D., Department for Child and Adolescent Psychiatry and Psychotherapy, University Clinic Freiburg, Freiburg, Germany

Katja Schneider-Momm, M.D., Department for Child and Adolescent Psychiatry and Psychotherapy, University Clinic Freiburg, Freiburg, Germany

Eberhard Schulz, M.D., Child and Adolescent Psychiatry, University Hospital Freiburg, Freiburg, Germany


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.2 Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders in Children and Adolescents: A Placebo-Controlled, Randomized, Double-Blind Clinical Trial